title: Synapsin II Regulation of GABAergic Synaptic Transmission Is Dependent on Interneuron Subtype.
abstract: Synapsins are epilepsy susceptibility genes that encode phosphoproteins reversibly associated with synaptic vesicles. Synapsin II (SynII) gene deletion produces a deficit in inhibitory synaptic transmission, and this defect is thought to cause epileptic activity. We systematically investigated how SynII affects synchronous and asynchronous release components of inhibitory transmission in the CA1 region of the mouse hippocampus. We found that the asynchronous GABAergic release component is diminished in SynII-deleted (SynII(-)) slices. To investigate this defect at different interneuron subtypes, we selectively blocked either N-type or P/Q-type Ca2+channels. SynII deletion suppressed the asynchronous release component at synapses dependent on N-type Ca2+channels but not at synapses dependent on P/Q-type Ca2+channels. We then performed paired double-patch recordings from inhibitory basket interneurons connected to pyramidal neurons and used cluster analysis to classify interneurons according to their spiking and synaptic parameters. We identified two cell subtypes, presumably parvalbumin (PV) and cholecystokinin (CCK) expressing basket interneurons. To validate our interneuron classification, we took advantage of transgenic animals with fluorescently labeled PV interneurons and confirmed that their spiking and synaptic parameters matched the parameters of presumed PV cells identified by the cluster analysis. The analysis of the release time course at the two interneuron subtypes demonstrated that the asynchronous release component was selectively reduced at SynII(-) CCK interneurons. In contrast, the transmission was desynchronized at SynII(-) PV interneurons. Together, our results demonstrate that SynII regulates the time course of GABAergic release, and that this SynII function is dependent on the interneuron subtype.SIGNIFICANCE STATEMENTDeletion of the neuronal protein synapsin II (SynII) leads to the development of epilepsy, probably due to impairments in inhibitory synaptic transmission. We systematically investigated SynII function at different subtypes of inhibitory neurons in the hippocampus. We discovered that SynII affects the time course of GABA release, and that this effect is interneuron subtype specific. Within one of the subtypes, SynII deficiency synchronizes the release and suppresses the asynchronous release component, while at the other subtype SynII deficiency suppresses the synchronous release component. These results reveal a new SynII function in the regulation of the time course of GABA release and demonstrate that this function is dependent on the interneuron subtype.
authors.affiliation: Department of Neurology.|Neuroscience Department, Universidad Central del Caribe, Bayamon, Puerto Rico 00960.
authors.forename: Pedro
authors.identifier: 0000-0002-7446-8103
authors.initials: P
authors.lastname: Feliciano
authors.affiliation: Department of Neurology.|Department of Anatomy and Cell Biology, and.|Neuroscience Department, Universidad Central del Caribe, Bayamon, Puerto Rico 00960.
authors.forename: Heidi
authors.identifier: 0000-0002-5486-0773
authors.initials: H
authors.lastname: Matos
authors.affiliation: Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, and.
authors.forename: Rodrigo
authors.identifier: 0000-0002-9035-6590
authors.initials: R
authors.lastname: Andrade
authors.affiliation: Department of Neurology, mbykhovs@med.wayne.edu.|Department of Anatomy and Cell Biology, and.|Neuroscience Department, Universidad Central del Caribe, Bayamon, Puerto Rico 00960.
authors.forename: Maria
authors.initials: M
authors.lastname: Bykhovskaia
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004558:Electric Stimulation; D005260:Female; D006624:Hippocampus / Q000166:cytology*; D066298:In Vitro Techniques; D053444:Inhibitory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D007395:Interneurons / Q000502:physiology*; D008164:Luminescent Proteins / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010320:Parvalbumins / Q000235:genetics / Q000378:metabolism; D013569:Synapses; D016704:Synapsins / Q000235:genetics / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*; D020867:omega-Agatoxin IVA / Q000494:pharmacology; D020866:omega-Conotoxin GVIA / Q000494:pharmacology
chemical_list: D002121:Calcium Channel Blockers; D008164:Luminescent Proteins; D010320:Parvalbumins; D016704:Synapsins; D020867:omega-Agatoxin IVA; D005680:gamma-Aminobutyric Acid; D020866:omega-Conotoxin GVIA
keywords: CCK; GABA; PV; epilepsy; hippocampus; inhibitory